Researchers work out the early steps that drive malignancy

By Samantha Black, PhD, The Science Advisory Board staff writer

December 18, 2019 -- Researchers from Yale University have identified cellular characteristics that lead to the early stages of malignancy. They state that in at least one form of blood cancer, cells with cancer-causing lesions can remain normal until cell division speeds up the process. The results were published in Nature Communications on December 18.

Not all cells carrying oncogenes transform into cancer, which leads scientists to question what discriminates a cell to transformed and others to remain normal. This process has been well-described for some solid tumors, where genetic lesions, or epigenetic alterations, are thought to be the cause. But not in other cancers, with low mutational loads such as those of hematopoietic origin, are unknown. The researchers wanted to determine the cellular traits that contribute to the acquisition of de novo malignancy in blood cancer.

"Many people with cancer-causing genes remain healthy for many, many years,'' said senior author Shangqin Guo, assistant professor of cell biology and a researcher at the Yale Stem Cell Center. "So, in these cases, you have to wonder whether the dogma 'mutations cause cancer' is the complete truth."

The research focused on granulocyte-macrophage progenitors (GMPs) that allow mixed lineage leukemia (MLL) fusion oncogene-mediated transformations. They observed that the progenitors produced two types of progeny: differentiated cells, or malignant cells that could develop into lethal acute myeloid leukemia (AML). AML carries the lowest number of mutations among known human cancers.

They introduced a leukemia-causing mutation, MLL-AF9, into mice genomes and tracked individual blood cells for indicators of transformation. While the great majority of cells remained normal, the few cells that divided most quickly almost always became malignant. The rapidly proliferating, immature myeloid progenitor cell state initiates transformation when this cell state is perpetuated by MLL-AF9 expression, fulfilling the functional definition of malignancy.

"When a normal cell that divides quickly meets MLL-AF9, this combination creates a monster cell that is stuck in a state of perpetual fast division," Guo said. "Their more slowly cycling counterparts remain normal and do not display the malignant cancer traits, even in the presence of cancer-causing mutations."

Certain cell states, such as infection can trigger the proliferation of rapidly-dividing cells to combat pathogens, but which could, as this research shows, open the door to cancer. Alternatively, stem cells experience functional decline due to again, which requires increased proliferation of healthy stems cells to repair additional damage. The researchers suggest that this increase could also explain why people become more susceptible to cancer as they age.


Do you have a unique perspective on your research related to cancer biology or genetics? Contact the editor today to learn more.

---

Join The Science Advisory Board today!


New microscopy technique helps scientists understand cancer growth and spread
Researchers from Duke Cancer Institute have developed a new technique to observe stem cell mutations occurring in colon cancer.
New insights into why tumor suppressor proteins go awry in cancer
Researchers from Stowers Institute for Medical Research in Kansas City, MO have identified proteins that are involved in tumor growth and metastasis in...

Copyright © 2019 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
BioProcess International
September 21-24
Eastern Standard Time Zone (EST), Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter